You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
A brief iPad based screening measure for HIV associated neurocognitive disorders
SBC: Digital Artefacts LLC Topic: 105Despite significance advances in anti retroviral treatments HIV associated neurocognitive disorder HAND remains prevalent and can affect a broad range of everyday activities An effective brief cognitive screen that could be implemented in busy HIV clinics where clinicians have limited time to provide care for patients with complex medical psychiatric and cognitive conditions has the poten ...
STTR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health -
A DOPPLER SIMULATOR FOR VASCULAR ULTRASOUND TRAINING
SBC: SHEEHAN MEDICAL LLC Topic: NIBIBDESCRIPTION provided by applicant Doppler ultrasound is relied upon as the primary and often the only test used to diagnose vascular pathology Because variations in technical skill directly impact surgical referral decisions there is a strong clinical need to ensure that provides both attain and maintain skills in this procedure The problem we address is the lack of a quantitative or standar ...
STTR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health -
Aerosol Sampling and Microfluidic Analysis of Reactive Oxygen Species
SBC: ILLIONIX, LLC Topic: 113DESCRIPTIONprovided by applicantCardiovascular diseases and Asthma affects betweenandmillion people in the United States includingmillion childrenduring the pastyearsits incidence worldwide has doubledAsthma is responsible formillion person days of restricted activity anddeaths per yearamounting to $billion in direct heath related coststhere is uncertainty about the specific factors that are contr ...
STTR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health -
An Automated Patient Chart Error Detection System for Radiation Therapy
SBC: Infondrian LLC Topic: 101Project Summary/Abstract Every year, approximately 1,200 severe mistreatments happen in radiation therapy. Radiation therapy lawsuits rank in the top third of all medical specialties with an average of $313,000 per claim settled or litigated. The current method for detecting treatment errors is by a weekly patient chart check, where each treatment record is manually reviewed on a weekly basis. Thi ...
STTR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health -
Antigen Detection assay for the Diagnosis of Melioidosis
SBC: Inbios International Inc Topic: NIAIDDESCRIPTION provided by applicant Burkholderia pseudomallei is a Gram negative bacterium that is the causative agent of melioidosis The bacterium causes significant morbidity and mortality in tropical regions and endemic areas are expanding Melioidosis is difficult to trea and diagnose due to the fact that B pseudomallei is resistant to common antibiotics and symptoms are non specific Morta ...
STTR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health -
Aptamers for Imaging and Therapy
SBC: Aptalogic, Inc. Topic: N/ADESCRIPTION (provided by applicant): Phase I The current proposal describes the selection of an aptamer that recognizes the drug PD173955, which is one of large family of substituted pyrido[2,3-d]pyrimidine inhibitors of tyrosine protein kinases. An aptamer is a single stranded nucleic acid that acts like an antibody but that can be expressed and function inside cells. The PD173955 RNA aptamer wi ...
STTR Phase II 2006 Department of Health and Human ServicesNational Institutes of Health -
ASCEND, AcceleratingÃÂÃÂ Solutions forÃÂÃÂ Commercialization andÃÂÃÂ EntrepreneurialÃÂÃÂ Development in the Mountain West IDeA States
SBC: VIRTICI LLC Topic: 500Project Summary The objective of this proposal is to create a Mountain West region technology Accelerator Hub to conduct research on developing, implementing, and testing a comprehensive collateral and consulting offering for promoting biomedical entrepreneurship, technology transfer, management, small business finance, and additional business skills needed to commercialize basic research to enhan ...
STTR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health -
A Sparse-readout Quantitative PET scanner for breast cancer therapy optimization
SBC: PET/X LLC Topic: 102Our goal is to improve how breast cancer therapies are matched to individual breast-cancer patients with early- stage disease by providing a timely evaluation of therapy efficacy during the window of opportunity between diagnosis and surgical resection. In so doing, we aim to direct patients more quickly to effective therapies, improving outcomes, and reducing toxicities and healthcare costs from ...
STTR Phase II 2020 Department of Health and Human ServicesNational Institutes of Health -
Autologous HIV-1 resistant T cells through accelerated CCR5 gene disruption
SBC: PRECISION GENOME ENGINEERING, INC. Topic: NIGMSDESCRIPTION (provided by applicant): Treating patients infected with Human Immunodeficiency Virus-1 (HIV-1) is a substantial clinical challenge with evolving pharmaceutical drug and dosing options. Treatments should improve the health and quality of life for HIV-infected individuals by reducing viremia and preserving immunological function. Currents therapeutic approaches utilize combination antir ...
STTR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health -
BioHDF- Open Binary File Standards for Bioinformatics
SBC: GEOSPIZA, INC. Topic: N/ADESCRIPTION (provided by applicant): The first wave of Next Generation ( Next Gen ) sequencing technologies combines molecular resolution with extremely high throughput to dramatically reduce sequencing costs and increase assay sensitivity and specificity. These technologies will provide large numbers of laboratories with Genome Center levels of throughput to make discoveries and develop new ass ...
STTR Phase II 2009 Department of Health and Human ServicesNational Institutes of Health